Navigation Links
Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 Supplements

JERUSALEM, DEXTER, Michigan, February 11, 2013 /PRNewswire/ --

Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.



"We are excited to work with Valicor Renewables as our strategic extraction partner" says Dr. Isaac Berzin , CTO of Qualitas Health. "Exclusive access to Valicor's extraction technology gives us a significant technological advantage and reduces the time-to-market of our pure-EPA omega-3 oil from algae. Valicor's technology is proven and practical. It completes the necessary portfolio of technologies needed to manufacture an algae-based Omega-3 supplement on a commercial scale."

"The collaboration between Qualitas and Valicor brings together best-in-class cultivation and strain technology with best-in-class class extraction technology, protected by robust patents" says Dr. Brian Goodall , VP. Business Development at Valicor Renewables. "Valicor's extraction technology is designed to keep the natural algae polar lipids intact while avoiding the use of potentially harmful solvents".

About Qualitas Health:

Qualitas Health is a privately-held company developing high-value vegetarian food supplements and pharmaceutical ingredients based on microalgae. Building on over 10 years' experience in algae cultivation and extraction from the biofuel sector, the company's team has developed a unique and proprietary technology for strain selection, sustainable algae farming, harvesting and oil processing. The technology allows for the effective production of proprietary premium Omega-3 algae oil for a wide range of applications.

About Valicor Renewables   (formerly SRS Energy):

Headquartered in Dexter, Michigan, Valicor services clients throughout the United States in the automotive, aerospace, alternative fuels, algae-derived products, power generation, and steel industries. The company operates three business groups, Environmental Services, Separation Technologies and Renewables, concentrating on the advancement of its technologies in processes and fluid management to meet client needs.  Since beginning the Algae Extraction Program in 2007, Valicor Renewables has established transformative new techniques for the extraction and fractionation of algae oil.  The development of the patent pending Valicor Algafrac™ technologies has provided for commercially scalable processes which efficiently and cost-effectively extract both polar and non-polar lipids.

Yuri Shoshan

SOURCE Qualitas Health Ltd
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The California Healthcare Institute Responds to New Efforts to Repeal the Federal Medical Device Excise Tax
2. Trovagene to Present at Leerink Swan Global Healthcare Conference
3. EU Study Finds UK Health Product Benefit Metric Flawed
4. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
5. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
6. Life Technologies to Present at Leerink Swann Global Healthcare Conference
7. Topricin Pain Relief and Healing Cream Selected by Healthy Holistic Living as one of the Top 100 Green Products of 2012
8. Nutrex Hawaii Hawaiian Astaxanthin Microalgae May be the Secret to Better Eye Health
9. Providence Health & Services Selects Conflict of Interest Management System
10. California Healthcare Institute Appoints Allergan CEO Chairman of the Board, Elects New Board Members
11. Dr. Alexander Fleming on Searching for Solutions to Metabesity and Healthy Aging
Post Your Comments:
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... DIEGO , Nov. 25, 2015  Neurocrine Biosciences, ... Kevin Gorman , President and CEO of Neurocrine Biosciences, ... Healthcare Conference in New York . ... to visit the website approximately 5 minutes prior to ... A replay of the presentation will be available on ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... 2015 Today, LifeBEAM , a ... 2XU, a global leader in technical performance sports ... with advanced bio-sensing technology. The hat will allow ... key biometrics to improve overall training performance. As ... will bring together the most advanced technology, extensive ...
Breaking Biology News(10 mins):